Cuadrado, A., Kügler, S., & Lastres-Becker, I. (2018). Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy.
Citación estilo ChicagoCuadrado, Antonio, Sebastian Kügler, y Isabel Lastres-Becker. Pharmacological Targeting of GSK-3 and NRF2 Provides Neuroprotection in a Preclinical Model of Tauopathy. 2018.
Cita MLACuadrado, Antonio, Sebastian Kügler, y Isabel Lastres-Becker. Pharmacological Targeting of GSK-3 and NRF2 Provides Neuroprotection in a Preclinical Model of Tauopathy. 2018.
Precaución: Estas citas no son 100% exactas.